• Percutaneous Imaging-guided Cryoblation of the Anterior Abdominal Wall Endometriosis Scars

  NCT06108167

  Unknown statusObservationalUpdated Nov 2, 2023
• Efficacy of Cryoablation of Abdominal Wall Endometriosis

  NCT03627676

  Unknown statusInterventionalNot ApplicableUpdated Mar 14, 2019
• Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer

  NCT06387173

  Active, not recruitingObservationalUpdated May 11, 2026
• Study to Evaluate the Efficacy of Percutaneous Cryoablation for Renal Tumours < 4cm in Patients Who Are Not Candidates for Partial Nephrectomy

  NCT01471002

  CompletedInterventionalNot ApplicableUpdated Apr 8, 2016
• Percutaneous Cryoablation of Low-risk Early Breast Cancer

  NCT06300125

  RecruitingObservationalUpdated Jan 6, 2026
• Percutaneous Radiofrequency Ablation of Parietal Endometriosis (PRFA)

  NCT04333017

  CompletedInterventionalNot ApplicableUpdated Aug 8, 2025

ClinicalTrials.gov ID

NCT06356831

Lead Sponsor

Centre Hospitalier Intercommunal CreteilOTHER

Overall Status

Recruiting

Study Type

Observational

Enrollment

300Estimated

Last Update Posted

Nov 28, 2025Actual

Start Date

Jun 15, 2024Actual

Primary Completion Date

Jul 31, 2027Estimated

Completion Date

Jan 31, 2028Estimated

Official Title

National Registry of Surgical Treatment and Percutaneous Cryoablation of Parietal Endometriosis

Brief Summary

National multicentric registry of a cohort of patient with suffering parietal endometriosis, carried out by a multidisciplinary radiosurgery team

Detailed Description

Patient who suffering of parietal endometriosis treat by cryoablation or chirurgical will be recorded in national registry. the patient will be follow during 3 years after treatement.

• Endometriosis
• Cryotherapy Effect
• Surgical
• Radiology

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

Female

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• Presence of parietal endometriosis: with suggestive clinical and imaging criteria (MRI and ultrasound)
• Symptomatic parietal endometriosis (VAS > 3 OR bothersome bleeding OR reported impact on quality of life)

Exclusion Criteria:

• Endometriosis not affecting the anterior wall of the abdomen (as deep pelvic muscle: ilio-psoas, obturators, perineal, ischio-anal fossa)
• Minor patient (< 18 years)
• Pregnant patient at any trimester
• Patient with hemostasis disorders (constitutional or acquired)
• Patient with systemic infection or localized scar infection upon inclusion.
• Patient with contraindications to MRI
• Female patient with a planned medical or surgical procedure for the duration of the study that may interfere with the proper conduct of the study.
• Patient unable to understand the information provided
• Patient who is not affiliated to the social security system
• Patient under curatorship or tutorship
• Patient with a nodule of primary or secondary malignant tumor origin

Observational Model

Cohort

Time Perspective

Prospective

Lead Sponsor

Centre Hospitalier Intercommunal CreteilOTHER

leo.razakamanantsoa@chicreteil.fr0157023567

alexandre.galant@chu-lyon.fr04 78 86 51 15

JULIEN.FRANDON@chu-nimes.fr04 66 76 60 63

alexis.nobileau@aphp.fr01 56 01 70 88

charles.roux@aphp.fr0142165530